INTERLEUKIN-1-BETA (IL-1-BETA), IL-1 RECEPTOR ANTAGONIST, AND TNF-ALPHA PRODUCTION IN WHOLE-BLOOD

被引:88
|
作者
NERAD, JL
GRIFFITHS, JK
VANDERMEER, JWM
ENDRES, S
POUTSIAKA, DD
KEUSCH, GT
BENNISH, M
SALAM, MA
DINARELLO, CA
CANNON, JG
机构
[1] NEW ENGLAND MED CTR,DEPT MED,BOX 068,750 WASHINGTON ST,BOSTON,MA 02111
[2] INT CTR DIARRHOEAL DIS RES,DHAKA,BANGLADESH
[3] TUFTS UNIV,SCH MED,BOSTON,MA 02111
关键词
INTERLEUKIN-1; TUMOR NECROSIS FACTOR; INTERLEUKIN-1 RECEPTOR ANTAGONIST; WHOLE BLOOD ASSAY; CYTOKINE;
D O I
10.1002/jlb.52.6.687
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ability of an individual to mount defense responses to infection depend in part on the capacity to produce cytokines such as interleukin 1 (IL-1) and tumor necrosis factor (TNF). The specialized equipment, labor intensity, and sterile practice required for the standard in vitro evaluation of cytokine production can make such evaluation impractical in some clinical situations. We report a method for stimulating whole blood to produce cytokines that can be implemented in laboratories without tissue culture facilities and requires minimal sample preparation. IL-1beta and TNFalpha production in whole blood samples was stimulated with endotoxin and/or phytohemagglutinin in standard EDTA-containing vacuum collection tubes. After incubation, plasma was removed and frozen for later assay. Comparison of this whole blood method with isolated mononuclear cell cultures indicated a significant correlation for IL-1beta production (r = 0.746, P = 0.005). This technique also produced the newly described cytokine, IL-1 receptor antagonist. We conclude that the whole blood method is an acceptable alternative to isolated cell culture methods for measuring IL-10 in situations that preclude the standard in vitro approach.
引用
收藏
页码:687 / 692
页数:6
相关论文
共 50 条